It’s not every day you can learn what’s on the minds of benefits leaders from dozens of top U.S. employers. The Employer Health Innovation Roundtable (EHIR) does it on a regular basis, most recently on topics of transparency and cost savings in pharmacy benefits. You may not know EHIR, but you would recognize its members. […]
Top 5 Things Employers Want from Pharmacy Benefits Read More »
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
Humira Biosimilars and other Biologic Alternatives Read More »
Utilization of specialty medications continues to rise, and so do costs for patients and plan sponsors. Thanks to these rising costs, we see more plans choosing to implement copay adjustment programs, but it’s crucial to understand how they fit into your benefit and where they improve or hinder your plan.
Specialty Copay Programs – Accumulate, Maximize or Avoid? Read More »
Each month, our pharmacists share clinical insights, market trends and real-life savings examples specific to some of the most common conditions. This month we take a look at Alzheimer’s Disease.
On One Condition – Alzheimer’s Disease Read More »
